In replay of a courtroom battle that ended in a mistrial last year, a federal jury voted unanimously that Merck’s Fosamax osteoporosis drug was responsible for causing jawbone deterioration suffered by a Florida woman, who was awarded $8 million in compensatory damages (here is the lawsuit).
Read article at pharmalot.com
No comments:
Post a Comment